Farther Finance Advisors, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Farther Finance Advisors, LLC
- $6.63 Trillion
- Q3 2025
A detailed history of Farther Finance Advisors, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 602 shares of EYPT stock, worth $7,506. This represents 0.0% of its overall portfolio holdings.
Number of Shares
602
Previous 353
70.54%
Holding current value
$7,506
Previous $3.32 Million
158.04%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EYPT
# of Institutions
162Shares Held
67MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$104 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$84.8 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$84.8 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$55.1 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$53.6 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $425M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...